Eri Kawata

1.6k total citations
42 papers, 842 citations indexed

About

Eri Kawata is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Eri Kawata has authored 42 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 17 papers in Genetics and 13 papers in Oncology. Recurrent topics in Eri Kawata's work include Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Eri Kawata is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers). Eri Kawata collaborates with scholars based in Japan, Canada and United States. Eri Kawata's co-authors include Junya Kuroda, Shinya Kimura, Eishi Ashihara, Yuri Kamitsuji, Taira Maekawa, Asumi Yokota, Masafumi Taniwaki, Kiyoshi Sato, Miki Takeuchi and Ruriko Tanaka and has published in prestigious journals such as Blood, Cancer Research and Scientific Reports.

In The Last Decade

Eri Kawata

38 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eri Kawata Japan	14	455	327	279	188	177	42	842
Yuri Kamitsuji Japan	16	449 1.0×	294 0.9×	369 1.3×	223 1.2×	174 1.0×	32	929
Susanne Herndlhofer Austria	16	756 1.7×	443 1.4×	244 0.9×	266 1.4×	267 1.5×	41	1.1k
Devendra Hiwase Australia	20	944 2.1×	489 1.5×	378 1.4×	296 1.6×	174 1.0×	107	1.3k
Michal Bar‐Natan United States	15	719 1.6×	364 1.1×	524 1.9×	312 1.7×	67 0.4×	41	1.3k
Jiří Mayer Czechia	11	748 1.6×	679 2.1×	162 0.6×	161 0.9×	320 1.8×	48	1.0k
Abdulraheem Yacoub United States	15	467 1.0×	551 1.7×	366 1.3×	206 1.1×	212 1.2×	122	917
Antony C. Cambareri Australia	12	505 1.1×	342 1.0×	204 0.7×	181 1.0×	233 1.3×	14	885
Mirosław Majewski Poland	16	308 0.7×	279 0.9×	522 1.9×	456 2.4×	195 1.1×	28	1.4k
Lurdes Zamora Spain	13	328 0.7×	253 0.8×	280 1.0×	271 1.4×	45 0.3×	55	824
Tobias Berg Canada	19	402 0.9×	231 0.7×	856 3.1×	211 1.1×	52 0.3×	60	1.3k

Countries citing papers authored by Eri Kawata

Since Specialization

Citations

This map shows the geographic impact of Eri Kawata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Kawata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Kawata more than expected).

Fields of papers citing papers by Eri Kawata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Kawata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Kawata. The network helps show where Eri Kawata may publish in the future.

Co-authorship network of co-authors of Eri Kawata

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Kawata. A scholar is included among the top collaborators of Eri Kawata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Kawata. Eri Kawata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Onishi, Akio, Shinsuke Mizutani, Taku Tsukamoto, et al.. (2023). Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti–SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms. Infection and Drug Resistance. Volume 16. 509–519. 3 indexed citations

Boyd, Allison L., Justin Lu, Jennifer Reid, et al.. (2023). Leukemic progenitor compartment serves as a prognostic measure of cancer stemness in patients with acute myeloid leukemia. Cell Reports Medicine. 4(7). 101108–101108. 6 indexed citations

Kobayashi, Tsutomu, Mitsushige Nakao, Ryoichi Takahashi, et al.. (2022). Watchful waiting is an acceptable treatment option for asymptomatic primary ocular adnexal mucosa‐associated lymphoid tissue lymphoma: A retrospective study. Cancer Medicine. 12(3). 3134–3144. 4 indexed citations

Chin‐Yee, Benjamin, Ian Cheong, Cyrus C. Hsia, et al.. (2022). A Rational Approach to JAK2 Mutation Testing in Patients with Elevated Hemoglobin: Results from the JAK2 Prediction Cohort (JAKPOT) Study. Journal of General Internal Medicine. 38(8). 1828–1833. 6 indexed citations

Kawata, Eri, Benjamin D. Hedley, Benjamin Chin‐Yee, et al.. (2021). Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?. International Journal of Laboratory Hematology. 44(2). 333–341. 2 indexed citations

Uoshima, Nobuhiko, Takahiro Fujino, Taku Tsukamoto, et al.. (2021). Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma. Diagnostics. 11(9). 1724–1724. 5 indexed citations

Chin‐Yee, Benjamin, Ian Cheong, Cyrus C. Hsia, et al.. (2021). A Prediction Rule to Guide JAK2 Testing in Patients with Suspected Polycythemia Vera. Blood. 138(Supplement 1). 4635–4635.

Kawata, Eri, et al.. (2021). Splanchnic vein thrombosis: Clinical manifestations, risk factors, management, and outcomes. Thrombosis Research. 202. 90–95. 12 indexed citations

Kawata, Eri, Alejandro Lazo‐Langner, Anargyros Xenocostas, et al.. (2020). Clinical value of next‐generation sequencing compared to cytogenetics in patients with suspected myelodysplastic syndrome. British Journal of Haematology. 192(4). 729–736. 8 indexed citations

10.

Tsukamoto, Taku, Masakazu Nakano, Ryuichi Sato, et al.. (2017). High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif. Scientific Reports. 7(1). 14039–14039. 14 indexed citations

11.

Okabe, Masahiro, Hiroki Yamaguchi, Kensuke Usuki, et al.. (2015). Clinical features of Japanese polycythemia vera and essential thrombocythemia patients harboring CALR, JAK2V617F, JAK2Ex12del, and MPLW515L/K mutations. Leukemia Research. 40. 68–76. 11 indexed citations

12.

Chinen, Yoshiaki, Junya Kuroda, Yuji Shimura, et al.. (2014). Phosphoinositide Protein Kinase PDPK1 Is a Crucial Cell Signaling Mediator in Multiple Myeloma. Cancer Research. 74(24). 7418–7429. 28 indexed citations

13.

Kuroda, Junya, Yutaka Kobayashi, Teruaki Akaogi, et al.. (2011). ADAMTS‐13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin. American Journal of Hematology. 87(1). 116–119. 11 indexed citations

14.

Kawata, Eri, Eishi Ashihara, Yoko Nakagawa, et al.. (2010). Galectin‐9 ameliorates acute GVH disease through the induction of T‐cell apoptosis. European Journal of Immunology. 41(1). 67–75. 40 indexed citations

15.

Yokota, Asumi, Shinya Kimura, Ruriko Tanaka, et al.. (2009). Osteoclasts are involved in the maintenance of dormant leukemic cells. Leukemia Research. 34(6). 793–799. 14 indexed citations

16.

Kuroda, Junya, Yuri Kamitsuji, Shinya Kimura, et al.. (2008). Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and β-catenin. International Journal of Hematology. 87(5). 507–515. 48 indexed citations

17.

Kuroda, Junya, Shinya Kimura, Andreas Strasser, et al.. (2007). Apoptosis-based dual molecular targeting by INNO-406, a second-generation Bcr-Abl inhibitor, and ABT-737, an inhibitor of antiapoptotic Bcl-2 proteins, against Bcr-Abl-positive leukemia. Cell Death and Differentiation. 14(9). 1667–1677. 57 indexed citations

18.

Uchida, Ryo, Eishi Ashihara, Kiyoshi Sato, et al.. (2007). γδT cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface. Biochemical and Biophysical Research Communications. 354(2). 613–618. 52 indexed citations

19.

Segawa, Hidekazu, Shinya Kimura, Junya Kuroda, et al.. (2005). Zoledronate synergises with imatinib mesylate to inhibit Ph⁺ primary leukaemic cell growth. British Journal of Haematology. 130(4). 558–560. 20 indexed citations

20.

Kawata, Eri, Junya Kuroda, Shinya Kimura, et al.. (2002). Aplastic anemia evolving into overt myelodysplastic syndrome/acute myeloid leukemia with t(3;5)(p25;q31). Cancer Genetics and Cytogenetics. 137(2). 91–94. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact